Published in Br Med J on March 22, 1975
Simultaneous assay of immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin in plasma of normal human subjects, patients with ACTH/lipotropin hypersecretory syndromes, and patients undergoing chronic hemodialysis. J Clin Invest (1981) 0.87
Role of the kidney in regulating plasma immunoreactive beta-melanocyte-stimulating hormone. Br Med J (1976) 0.81
A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J Clin Pathol (1962) 18.80
A radioimmunoassay for rat plasma ACTH. Endocrinology (1971) 3.35
Adrenocorticotrophic and melanocyte-stimulating peptides in the human pituitary. Biochem J (1974) 3.32
Isolation and amino-acid sequence of beta-LPH from sheep pituitary glands. Nature (1965) 2.44
Proposed system of terminology for preparations of adrenocorticotropic hormone. Science (1959) 1.61
A reappraisal of human beta MSH. Nature (1974) 1.46
Dissociation of the disappearance of bioactive and radioimmunoreactive ACTH from plasma in man. J Clin Endocrinol Metab (1971) 1.18
A comparison of the -melanocyte-stimulating hormone and corticotropin response to hypoglycemia. J Clin Endocrinol Metab (1973) 0.94
[Melanoderma in Bright's disease; two new cases]. Ann Dermatol Syphiligr (Paris) (1958) 0.81
Letter: Adrenal hormones in dialysates. N Engl J Med (1974) 0.81
Beta-melanocyte stimulating hormone. Proc R Soc Med (1974) 0.81
Studies of lipochromes (urochromes) in uremic patients and normal controls I: the elimination of plasma lipochromes by hemodialysis. Trans Am Soc Artif Intern Organs (1969) 0.80
Studies on the release and degradation of the human melanocyte stimulating hormone. Proc R Soc Med (1974) 0.80
A radioimmunoassay for rat plasma ACTH. Endocrinology (1971) 3.35
Functional anatomy of the lymphocyte in immunological reactions in vitro. J Exp Med (1966) 2.91
Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol (1991) 2.79
A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature (1992) 2.49
A collaborative scheme for tissue typing and matching in renal transplantation. Lancet (1969) 2.26
Why should women have lower reference limits for haemoglobin and ferritin concentrations than men? BMJ (2001) 2.23
Long-term treatment of acromegaly with bromocriptine. Br Med J (1977) 2.18
Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet (1982) 1.98
Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol (2000) 1.97
Factors affecting the reactivity of human lymphocytes in vitro. I. Cell number, duration of culture and surface area. J Immunol (1967) 1.96
Increased beta-endorphin but not met-enkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain. Lancet (1980) 1.94
Cloning and characterization of cDNAs encoding human gastrin-releasing peptide. Proc Natl Acad Sci U S A (1984) 1.93
Clobetasone butyrate, a new topical corticosteroid: clinical activity and effects on pituitary-adrenal axis function and model of epidermal atrophy. Br Med J (1975) 1.87
Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat Genet (1995) 1.83
Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet (1996) 1.78
Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev (1996) 1.75
Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. Kidney Int (2001) 1.71
Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat Genet (1995) 1.71
Pituitary-adrenal function after occlusive topical therapy with betamethasone-17-valerate. Lancet (1967) 1.71
Altered laminin 5 expression due to mutations in the gene encoding the beta 3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa. J Invest Dermatol (1995) 1.69
Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome. Nat Genet (1997) 1.68
Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) (1986) 1.62
Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J (1975) 1.61
Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancet (1980) 1.60
Abdominal hernias in patients receiving continuous ambulatory peritoneal dialysis. Br Med J (Clin Res Ed) (1981) 1.59
A new method for recovery of exudates from normal and inflamed human skin. Clin Exp Dermatol (1977) 1.58
Ectopic hormone production by non-endocrine tumours. Clin Endocrinol (Oxf) (1974) 1.56
Lung tumours and ACTH production. Clin Endocrinol (Oxf) (1977) 1.54
Mast cell population density, blood vessel density and histamine content in normal human skin. Br J Dermatol (1979) 1.53
Cancer in patients receiving dialysis. Br Med J (1980) 1.52
Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar keratoderma. Hum Mol Genet (1999) 1.52
The polyneuropathy of chronic renal failure. Brain (1971) 1.49
A functional "knockout" of human keratin 14. Genes Dev (1994) 1.48
Epidermolysis bullosa pruriginosa: dystrophic epidermolysis bullosa with distinctive clinicopathological features. Br J Dermatol (1994) 1.47
Striate palmoplantar keratoderma resulting from desmoplakin haploinsufficiency. J Invest Dermatol (1999) 1.47
Influence of HLA matching and blood-transfusion on outcome of 502 London Transplant Group renal-graft recipients. Lancet (1976) 1.47
A reappraisal of human beta MSH. Nature (1974) 1.46
Adult-onset Still's disease. Twenty-year followup and further studies of patients with active disease. Arthritis Rheum (1982) 1.45
Linear streaking due to bleomycin. Clin Exp Dermatol (1987) 1.44
Cushing's syndrome. Clin Endocrinol Metab (1985) 1.44
The relationship between serum prolactin and immunocytochemical staining for prolactin in patients with pituitary macroadenomas. Clin Endocrinol (Oxf) (1985) 1.40
Ferritin and fertility. Lancet (1991) 1.40
Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy. Nephrol Dial Transplant (1989) 1.39
Pituitary peptide. Nat New Biol (1973) 1.39
Cyclosporin-induced renal magnesium leak in renal transplant patients. Nephrol Dial Transplant (1990) 1.38
Bromocriptine in management of large pituitary tumours. Br Med J (Clin Res Ed) (1982) 1.36
Influence of HL-A matching antigenic strength, and immune responsiveness on outcome of 349 cadaver renal grafts. 3 years' experience of the London transplant group. Lancet (1972) 1.36
N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. Hum Mol Genet (1999) 1.35
Sixteen months experience with cyclosporin-A in human kidney transplantation. Transplant Proc (1981) 1.35
Treatment of psoriasis with azathioprine. Br Med J (1974) 1.34
ACTH, lipotrophin and MSH in health and disease. Clin Endocrinol Metab (1977) 1.32
Cyclical combination chemotherapy and gonadal function. Retrospective study in males. Lancet (1979) 1.31
Development of a specific extracted radioimmunoassay for methionine enkephalin in human plasma and cerebrospinal fluid. J Endocrinol (1980) 1.31
Development and validation of a radioimmunoassay for peptides related to beta-melanocyte-stimulating hormone in human plasma: the lipotropins. J Clin Endocrinol Metab (1975) 1.30
Atherosclerotic renovascular disease causing renal impairment--a case for treatment. Clin Nephrol (1989) 1.28
The biosynthesis of hormones by non-endocrine tumours--a review. J Endocrinol (1975) 1.27
Development and validation of a specific radioimmunoassay for somatostatin in human plasma. Ann Clin Biochem (1979) 1.26
beta-Endorphin in human cerebrospinal fluid. Lancet (1978) 1.26
Multicentre collaboration in 162 tissue-typed renal transplants. The London and Regional Transplant Group, March, 1969, to December, 1970. Lancet (1971) 1.25
Production of rabbit antibodies against carboxy-terminal epitopes encoded by bullous pemphigoid cDNA. J Invest Dermatol (1990) 1.24
Met-enkephalin circulates in human plasma. Nature (1980) 1.23
Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. Lab Invest (1991) 1.23
Hepatitis-associated antigen and antibody in haemodialysis patients and staff. Br Med J (1970) 1.23
Rhabdomyolysis and systemic infection. Br Med J (Clin Res Ed) (1983) 1.22
Acupuncture in heroin addicts; changes in Met-enkephalin and beta-endorphin in blood and cerebrospinal fluid. Lancet (1979) 1.22
Evaluation of anchoring fibrils and other components of the dermal-epidermal junction in dystrophic epidermolysis bullosa by a quantitative ultrastructural technique. J Invest Dermatol (1985) 1.21
Type VII collagen is a normal component of epidermal basement membrane, which shows altered expression in recessive dystrophic epidermolysis bullosa. J Invest Dermatol (1988) 1.21
Pemphigus vulgaris: the manifestations and long-term management of 55 patients with oral lesions. Br J Dermatol (1999) 1.20
Metyrapone in long-term management of Cushing's disease. Br Med J (1977) 1.19
Comparison of betamethasone 17-valerate ointment with fluocortolone and fluocortolone caproate ointment. Br Med J (1967) 1.19
Compound heterozygosity for a dominant glycine substitution and a recessive internal duplication mutation in the type XVII collagen gene results in junctional epidermolysis bullosa and abnormal dentition. Am J Pathol (1996) 1.19
Transthoracic removal of midline thoracic disc protrusions causing spinal cord compression. J Neurosurg (1969) 1.18
Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients. J Thorac Cardiovasc Surg (1985) 1.18
A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. Hum Mol Genet (1995) 1.17
Human lung homotransplantation. Can Med Assoc J (1966) 1.16
Glycosylated haemoglobin in chronic renal failure. Br Med J (1979) 1.16
Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int (1981) 1.15
Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis. Br J Dermatol (1986) 1.15
Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary. Clin Endocrinol (Oxf) (1984) 1.15
Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis. J Cell Biol (1996) 1.14
Ulcerative sarcoidosis: a rare manifestation of a common disease. Clin Exp Dermatol (1984) 1.13
Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft recipient. Br Med J (Clin Res Ed) (1982) 1.13
Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector. Br J Dermatol (1973) 1.12
Alcohol-induced pseudo-Cushing's syndrome. Lancet (1977) 1.12
Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin-filament network involving keratins K5 and K14. J Invest Dermatol (1991) 1.12
The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones. Clin Endocrinol (Oxf) (1986) 1.12
Distribution of mast cells in human dermis: development of a mapping technique. Br J Dermatol (1979) 1.11
Lymphoid inhibitor of human lymphocyte DNA synthesis and mitosis in vitro. Nature (1969) 1.11
Thrombotic thrombocytopenic purpura. Recovery after splenectomy. Arch Intern Med (1966) 1.11
Specialized keratin expression pattern in human ridged skin as an adaptation to high physical stress. Br J Dermatol (1998) 1.10
Tetracycline and epidermolysis bullosa simplex: a new indication for one of the oldest and most widely used drugs in dermatology? Arch Dermatol (1999) 1.10
The premature ageing syndromes. Report of eight cases and description of a new entity named metageria. Br J Dermatol (1974) 1.10
Plasma immunoreactive corticotrophin and lipotrophin in Cushing's syndrome and Addison's disease. Br Med J (1977) 1.10
Ultrastructural morphometry of normal human dermal-epidermal junction. The influence of age, sex, and body region on laminar and nonlaminar components. J Invest Dermatol (1984) 1.10
Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol (Oxf) (1988) 1.10
Bronchopleural fistula--present-day study of an old problem. A review of 52 cases. Ann Thorac Surg (1971) 1.09
Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression. J Invest Dermatol (1993) 1.09